Posted in | News | Bionanotechnology

New Technology to Engineer Enhanced Composite Nanofibers for Biomedical Use

Ligaments, the meniscus of the knee, tendons and other such tissues present in the human body are collagen-based and fibrous and possess a structured configuration that imparts robustness necessary to endure mechanical loading.

Fibrous biomaterial developed by Penn Scientists (Credit:Brendon M. Baker, Ph.D.; Perelman School of Medicine, University of Pennsylvania)

Replacement of injured tissues with bioengineered materials requires careful three-dimensional reconstruction of the tissues’ unique architecture. The most popular treatment tool for meniscus tears of the knee, ACL, Achilles tendon ruptures and rotator cuff injuries is the use nano-sized fibers as scaffolds to direct tissue growth in a structured way. The drawback to this treatment method is that the scaffolds are not readily occupied by cells if the nanofibers are crammed in tight.

Scientists at University of Pennsylvania have developed a new technology by which scaffolds of composite nanofibers are loose enough for cells to occupy them while still retaining the ability to guide the tissue growth. The basis of this technology is the incorporation of a transitory space-holding element. By using the process of electro-spinning, the scientists engineered composites comprising of two types of fibers, viz. a polymer that degrades slowly and a water soluble polymer used to control the spacing between fibers by selective removal of the fiber. Dissolved polymer solutions were electrically charged which resulted in the explosion of the solution into a fine fiber spray that was arranged to fall into a rotating drum. The collected stretchable fabric can be either directly implanted or can be shaped as per the medical requirement. Lab tests show that these fibers possess tensile properties on par with human meniscus tissue. The team is currently testing these fibers on large animal models for orthopedic treatment.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, February 12). New Technology to Engineer Enhanced Composite Nanofibers for Biomedical Use. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=25364.

  • MLA

    Thomas, G.P.. "New Technology to Engineer Enhanced Composite Nanofibers for Biomedical Use". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=25364>.

  • Chicago

    Thomas, G.P.. "New Technology to Engineer Enhanced Composite Nanofibers for Biomedical Use". AZoNano. https://www.azonano.com/news.aspx?newsID=25364. (accessed November 21, 2024).

  • Harvard

    Thomas, G.P.. 2019. New Technology to Engineer Enhanced Composite Nanofibers for Biomedical Use. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=25364.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.